New stent aims to fix aortic arch without open surgery

NCT ID NCT07564375

Not yet recruiting Disease control Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a new device called the GORE Multibranch Arch Endoprosthesis for people with aortic arch conditions like aneurysms or dissections. The device is placed inside the blood vessel to repair the damaged area. The study will enroll 20 participants and follow them for 5 years to check if the device is safe and works as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GORE Multibranch Arch Endoprosthesis (MBA device) and GORE Ascending Stent Graft (ASG device)
What this could lead to: If successful, this device could offer a less invasive way to treat complex aortic arch problems, potentially avoiding open-heart surgery.
What could go wrong: This is a very early, small study (20 people) focused only on safety. The device may fail or cause serious complications like stroke or kidney failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PENETRATING AORTIC ULCERS (PAUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm, False Dissection, Thoracic Aorta Penetrating Atherosclerotic Ulcer thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PENETRATING AORTIC ULCERS (PAUS) PSEUDOANEURYSM THORACIC AORTIC ANEURYSM THORACIC AORTIC DISSECTION

More trials for these conditions

Other studies related to the condition(s) this trial covers.